The annual Al Yergey Mass Spectrometry Scientist Award, established in 2018, continues to commemorate the profound legacy of its namesake,…
Read More

The annual Al Yergey Mass Spectrometry Scientist Award, established in 2018, continues to commemorate the profound legacy of its namesake,…
Read More
Japan is rapidly solidifying its position as a premier destination for regenerative medicine research and development, a surge driven by…
Read More
Merck’s latest investigational drug, calderasib, is not merely another entry into the burgeoning field of KRAS G12C inhibition; it represents…
Read More
A multidisciplinary research team led by Yale University has successfully mapped the precise biological mechanism by which a naturally occurring…
Read More
The landscape of analytical chemistry, particularly within mass spectrometry (MS), is undergoing a profound transformation driven by the integration of…
Read More
Merck has unveiled its investigational KRAS G12C inhibitor, calderasib, positioning it not merely as another potent molecule in a rapidly…
Read More
Merck’s investigational KRAS G12C inhibitor, calderasib, is making headlines not for its standalone potency but for a strategically different attribute:…
Read More
The landscape of genomic science was irrevocably transformed by the advent of next-generation sequencing (NGS), a revolution largely spearheaded by…
Read More
The pharmaceutical industry, a cornerstone of global health and economic development, operates today within an increasingly interconnected and complex global…
Read More
Following a significant investment slump that began after the initial surge of capital during the early COVID-19 pandemic, the biotechnology…
Read More